|
UMIN-CTR Search Clinical Trials |
|
 UMIN-CTR English Home |
Glossary (Simple) |
FAQ |
Search clinical trials |
 |
Please be advised that prefix of UMIN-CTR registration number has been modified from "C" to "UMIN" since Aug 1 2006. |
|
This database is to disclose the information on clinical trials. |
|
It does not intend to advertise specific medications or treatments for medical professionals and general public. |
|
Search Clinical trials=>click here |
|
Trials are displayed in gray if they have not been updated for more than one year and the recruitment status is either "terminated" or "completed". |
|
Trials are displayed in green if they have not been updated for more than one year and the recruitment status is neither "terminated" nor "completed". |
|
All translation is performed by the Responsible Registrant. |
|
Paper clip on Dataset column indicates that the registration has dataset attached by UMIN individual cace data repository service. |
| Data set | Unique ID issued by UMIN/Date of disclosure of the study information | Title of the study (Brief title) | Condition | Name of primary sponsor | Recruitment status | Detail | History |
| C000000156 2005/09/13 |
Targeted busulfan and cyclophosphamide for allogeneic hematopoietic stem cell transplantation (C-SHOT 0301) | Chronic Myelogenous Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome | Completed | Detail | History | ||
| C000000154 2005/09/13 |
Randomized controlled Phase 3 trial of maintenance therapy in patients with adult acute promyelocytic leukemia (JALSG APL204 Study) | acute promyelocytic leukemia | Detail | History | |||
| C000000149 2005/09/13 |
Effect of local delivery of Evans blue on prevention of restenosis after coronary stenting | Angina pectoris, myocardial infarction | No longer recruiting | Detail | History | ||
| C000000140 2005/09/13 |
Acarbose and Secondary Prevention after Coronary Stenting | Abnormal Glucose Tolerance | No longer recruiting | Detail | History | ||
| C000000129 2005/09/13 |
Post-marketing study of cilostazol (Cilostazol Stroke Prevention Study II: CSPS II) | Patients with cerebral infarction (excluding cardiogenic cerebral embolism) | Completed | Detail | History | ||
| C000000194 2005/09/12 |
Phase III trial of neoadjuvant chemotherapy followed by surgery versus surgery alone for bulky stage I/II cervical cancer: Japan Clinical Oncology Group trial (JCOG0102) | Patients with cervical cancer | Terminated | Detail | History | ||
| C000000193 2005/09/12 |
Randomized phase III trial comparing adjuvant oral UFT/LV to 5-FU/l-LV in stage III colorectal cancer (JCOG-0205-MF) | Stage III colorectal cancer | Main results already published | Detail | History | ||
| C000000190 2005/09/12 |
GLSG, 2003, ADV | Chronic hepatitis B | Completed | Detail | History | ||
| C000000188 2005/09/12 |
A phase I study of TS-1 and docetaxel for advanced gastric cancer | advanced gastric cancer | Suspended | Detail | History | ||
| C000000187 2005/09/12 |
Poor PS:Gefitinib | PS 3 patients (or PS 4 patients because of bone or brain metastasis) with advanced adenocarcinoma of the lung. | Detail | History | |||
| C000000186 2005/09/12 |
Phase III study comparing FK506 with Cyclosporine A for prophylaxis of acute graft-versus-host disease after HLA-A, B and DRB1 genotypically matched unrelated bone marrow transplantation (C-SHOT 0404) | Acute leukemia, Chronic myeloid leukemia | Completed | Detail | History | ||
| C000000184 2005/09/12 |
Phase II study of gefitinib in untreated advanced non-small cell lung cancer with EGF receptor mutations | non-small cell lung cancer | Completed | Detail | History | ||
| C000000180 2005/09/12 |
Pilot study of 3 dimensional stereotactic radiotherapy and oral UFT for stage IB NSCLC. | non - small cell lung cancer, stageIB. | Completed | Detail | History | ||
| C000000179 2005/09/12 |
Phase III trial of doxorubicin / cyclophosphamide (AC), docetaxel (D), and alternating AC and D (AC-D) as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802) | Patients with Metatatic Breast Cancer | Completed | Detail | History | ||
| C000000178 2005/09/12 |
Clinical Trial to Test Efficacy and Safety of Autologous Peripheral Stem Cell Transplantation for Multiple Myeloma (C-SHOT 0401) | multiple myeloma | Completed | Detail | History | ||
| C000000177 2005/09/12 |
Amrubicin for Previously Treated Small Cell Lung Cancer | For patients with recurrent or relapsed small cell lung cancer | Completed | Detail | History | ||
| C000000175 2005/09/12 |
GLSG PEG/Rib 2005 | Chronic hepatitis C | Completed | Detail | History | ||
| C000000172 2005/09/12 |
Japan ACE (Antiplatelet therapy for Coil Embolization) Trial | Unruptured cerebral aneurysms | Detail | History | |||
| C000000168 2005/09/12 |
Phase I study of non-myeloablative conditioning regimen of Fludarabine/melphalan for hematopoietic stemcell transplantation from HLA matched sibling donors in patient with multiple myeloma that refractory or relapsed for autologous stem cell transplantation (C-SHOT0403) | Multiple myeloma that refractory or relapsed for autologous stem cell transplantation | Terminated | Detail | History | ||
| C000000165 2005/09/12 |
Study of Docetaxle and trastuzumab as preoperative chemotherapy for advanced-stage breast cancer with HER2 over expression | Breast Cancer | Detail | History | |||
| C000000162 2005/09/12 |
Cellular adoptive immunotherapy using CTL specific for hematopoietic-lineage minor histocompatibility antigen for the treatment of patients with relapsed leukemia following transplantation. | 1) RAEB, CMML 2) AML or ALL in induction failure or beyond first remission 3) Ph/p190-positive ALL at any stage 4) imatinib-resistant CML | Detail | History | |||
| C000000161 2005/09/12 |
Cellular adoptive immunotherapy targeting predetermined minor histocompatibility antigens for the treatment of patients with relapsed leukemia following transplantation. | 1) RAEB, CMML 2) AML or ALL in induction failure or beyond first remission 3) Ph/p190-positive ALL at any stage 4) imatinib-resistant CML | Detail | History | |||
| C000000157 2005/09/12 |
Randomized Study of Induction and Consolidation Therapy in Patients With Previously Untreated AML (JALSG AML201 Study) | Acute Myeloid Leukemia | Completed | Detail | History | ||
| C000000134 2005/09/12 |
Phase II study of topotecan and cisplatin for elderly small-cell lung cancer | Elderly small-cell lung cancer | Completed | Detail | History | ||
| C000000133 2005/09/12 |
Phase II of S-1 plus docetaxel versus docetaxel alone for relapsed non-small-cell lung cancer | platinum-pretreated patients with non-small-cell lung cancer | Completed | Detail | History | ||
| C000000132 2005/09/12 |
S-1 with radiotherapy for elderly locally advanced non-small-cell lung cancer | Elderly inoperable locally advanced non-small-cell lung cancer | Completed | Detail | History | ||
| C000000131 2005/09/12 |
Irinotecan and amrubicin for relapsed non-small-cell lung cance | Relapsed non-small-cell lung cancer | Completed | Detail | History | ||
| C000000130 2005/09/12 |
Topotecan and amrubicin for metastatic or relapsed small-cell lung cancer | Metastatic or relapsed small-cell lung cancer | Completed | Detail | History | ||
| C000000127 2005/09/12 |
HIPOP-OHP study | hypertension, dyslipidemia, glucose intolerance and smoking | Completed | Detail | History | ||
| C000000085 2005/09/12 |
OLCSG0007 | inoperable locally advanced non-small-cell lung cancer | Completed | Detail | History | ||
| C000000079 2005/09/12 |
Cisplatin and S-1 with radiotherapy for locally advanced non-small-cell lung cancer | inoperable locally advanced non-small-cell lung cancer | Completed | Detail | History | ||
| C000000160 2005/09/11 |
Randomized Controlled Trial for the Prevention of Intraventricular Hemorrhage by Indomethacin in Japanese Extremely Low Birth Weight Infants. | Extremely Low Birth Weight Infants (Intraventricular Hemorrhage , Patent ductus arteriosus) | No longer recruiting | Detail | History | ||
| C000000153 2005/09/10 |
Study of imatinib monotherapy and combination of imatinib with IFN or cytarabine ocfosfate for chronic-phase CML (JALSG CML202 Study) | Previously untreated chronic-phase chronic myelogenous leukemia | Completed | Detail | History | ||
| C000000100 2005/09/10 |
Randomized double blind trial for inhibitory effect of sulindac and etodorac on ACF | Subjects with aberrant crypt foci(ACF) | Completed | Detail | History | ||
| C000000151 2005/09/09 |
Phase II study of gefitinib in patients with EGFR mutation positive- advanced non-small cell lung cancer | non-small cell lung cancer | Completed | Detail | History | ||
| C000000150 2005/09/09 |
A Phase I/II Study of Amrubicine and Irinotecan in Patients with Advanced Small Cell Lung Cancer | small cell lung cancer | Completed | Detail | History | ||
| C000000148 2005/09/09 |
CCRT with CPT-11 | uterine cancer (squamous cell carcinoma, adeno- and/or adenosquamous cell carcinoma, endometrial carcinoma, carcinosarcoma) | Completed | Detail | History | ||
| C000000147 2005/09/09 |
A Randomized phase II study of docetaxel versus weekly carboplatin and CPT-11 for previously treated Non-Small cell lung cancer | second line chemotherapy for Non-Small cell lung cancer | Completed | Detail | History | ||
| C000000146 2005/09/09 |
Cisplatin-containing combination vs single-agent chemotherapy in elderly patients with adavanced non-small-cell lung cancer (JCOG0207 Elderly NSCLC/D vs DP) | non-small-cell lung cancer | Terminated | Detail | History | ||
| C000000145 2005/09/09 |
Dose-intensive weekly combination chemotherapy (cisplatin, vincristine, doxorubicin and etoposide) followed by cisplatin-etoposide therapy with concurrent thoracic irradiation: evaluation of a new treatment for limited-disease small-cell lung cancer. | limited-disease small-cell lung cancer | Completed | Detail | History | ||
| C000000137 2005/09/09 |
HOMED-BP Study | Untreated essential hypertensive patients | Completed | Detail | History | ||
| C000000115 2005/09/09 |
Weekly IP PAC+CBDCA for mullerian carcinoma | Gynecological Mullerian tumors, such as ovarian, tubal, and peritoneal cancers. | Completed | Detail | History | ||
| C000000144 2005/09/08 |
JET Study | Symptomatic internal carotid artery or middle cerebral artery occlusion or stenosis | Completed | Detail | History | ||
| C000000143 2005/09/08 |
A combination phase I study of topotecan with cisplatin for elderly small cell lung cancer | small cell lung cancer | Detail | History | |||
| C000000142 2005/09/08 |
PhaseII stady of gefitinib and in patients with relapsed advanced non-small cell lung cancer | relapsed advanced non-small cell lung cartinoma | Detail | History | |||
| C000000141 2005/09/08 |
A phase II study of Amrubicin in patients with previously treated small cell lung cancer | small cell lung cancer | Detail | History | |||
| C000000139 2005/09/08 |
MELT Japan | Middle cerebral artery embolism | Completed | Detail | History | ||
| C000000138 2005/09/08 |
Randomized phase II study of best available 5-FU versus low-dose Paclitaxiel in gastric cancer with peritoneal metastasis refractory to 5-FU containing regimen(JCOG0407) | gastric neoplasm | Completed | Detail | History | ||
| C000000136 2005/09/08 |
phase II study of gefitinib as a first-line therapy in elderly patients with lung adenocarcinoma. | lung adenocarcinoma | Completed | Detail | History | ||
| C000000135 2005/09/08 |
A combination phase II study of gemcitabine with carboplatin for previously untreated elderly non-small cell lung cancer. | Non-small cell lung cancer | Completed | Detail | History | ||
| C000000106 2005/09/08 |
J-RHYTHM Study | Atrial Fibrillation | Completed | Detail | History | ||
| C000000128 2005/09/07 |
A combination phase I/II study of topotecan with carboplatin for relapsed small cell lung cancer | relapsed small cell lung cancer | Completed | Detail | History | ||
| C000000126 2005/09/07 |
Immunohistochemical analysis of EGFR, HER2 and their phosphorylated status, and Insulin-like growth factor-1 receptor in tumor tissues obtained from non-small cell lung cancer patients treated with gefitinib | gefitinib in patients with NSCLC | Completed | Detail | History | ||
| C000000125 2005/09/07 |
Effectiveness of immunonutrition and synbiotics in liver transplant recipients. | Patients scheduled for living-donor liver transplantation. | Detail | History | |||
| C000000123 2005/09/07 |
Randomized phase III study of 5-FU versus MTX+5-FU in gastric cancer with peritoneal metastasis (JCOG0106-MF, MF/5FU) | gastric cancer with peritoneal metastasis | Completed | Detail | History | ||
| C000000122 2005/09/07 |
Randomized controlled trial to evaluate surgical approaches to gastric cancer invading the esophagus (JCOG9502) | gastric neoplasm | Completed | Detail | History | ||
| C000000119 2005/09/07 |
GEANE study | essential hypertension | Detail | History | |||
| C000000121 2005/09/06 |
Randomized controlled trial to evaluate para-aortic lymphadenectomy for gastric cancer (JCOG9501) | gastric neoplasm | Completed | Detail | History | ||
| C000000118 2005/09/06 |
A Phase II Trial of Gefitinib Monotherapy in Elderly Chemo-naïve Patients with Advanced Non–Small Cell Lung Cancer | Non small cell lung cancer | Detail | History | |||
| C000000117 2005/09/06 |
Phase 3 study of docetaxel vs vinorelbine in elderly patients with advanced non-small cell lung cancer | elderly patients with advanced non-small cell lung cancer | Completed | Detail | History | ||
| C000000116 2005/09/06 |
randomized study of Gemicitabine alone or UFT adjuvant chemotherapy for stage IB-IIIA non small cell lung cancer after complete resection | stage IB-IIIA non small cell lung cancer after complete resection | No longer recruiting | Detail | History | ||
| C000000114 2005/09/05 |
The safety and efficacy trial of primary chemo-radiotherapy for the early breast cancer (JCOG0306) | stage I to IIIA breast cancer | Completed | Detail | History | ||
| C000000113 2005/09/05 |
phase II study of irinotecan plus cisplatin followed by amrubicin in patients with extensive disease small-cell lung cancer. | extensive disease small-cell lung cancer | Completed | Detail | History | ||
| C000000112 2005/09/04 |
Phase II study of carboplatin-gemcitabine combination chemotherapy in elderly patients with advanced non–small cell lung cancer | non small cell lung cancer | Detail | History | |||
| C000000111 2005/09/04 |
Transarterial infusion chemotherapy with or without embolization in hepatocellular carcinoma | hepatocellular carcinoma | Completed | Detail | History | ||
| C000000054 2005/09/04 |
Phase I–II study of TS-1 and Carboplatin in advanced Non Small Lung Cancer | non small cell lung cancer | Detail | History | |||
| C000000035 2005/09/04 |
A Randomized Phase III trial of chemotherapy alone versus chemotherapy followed by gefitinib in stage IIIB/IV non-small cell lung cancer | Stage IIIB/IV Non-small cell lung cancer | No longer recruiting | Detail | History | ||
| C000000110 2005/09/02 |
Randomized phase II study of carboplatin / gemcitabine versus vinorelbine / gemcitabine in patients with advanced non-small cell lung cancer | Stage IIIb/IV NSCLC | Completed | Detail | History | ||
| C000000109 2005/09/02 |
A Phase II Study of Cisplatin, Etoposide and Concurrent Thoracic Irradiation Followed by Irinotecan and Cisplatin in Patients with Limited Small-Cell Lung Cancer | LD-SCLC | Completed | Detail | History | ||
| C000000108 2005/09/02 |
A randomized phase II/III study of ACNU versus Procarbazine plus ACNU as a postoperative chemoradiotherapy for astrocytoma grade 3 and 4(JCOG0305, ACNU+PCZ PhaseII/III) | astrocytoma grade 3/4 | Completed | Detail | History | ||
| C000000107 2005/09/01 |
DIANA study | Patients with impaired fasting glucose or type-2 diabetes mellitus, who had coronary artery diseases | No longer recruiting | Detail | History | ||
| C000000105 2005/09/01 |
Randomized Controlled Trial to Evaluate Laparoscopic versus Open Surgery for Colorectal Cancer(JCOG 0404,CRC Surg-LAP/OPEN) | Colorectal cancer | Completed | Detail | History | ||
| C000000084 2005/09/01 |
Second line chemotherapy consisting of weekly irinotecan and cisplatin for relapsed/first line resistant non-small cell lung carcinoma - phase II study | Non-small-cell lung carcinoma | Completed | Detail | History | ||
| C000000082 2005/09/01 |
Phase III trial of postoperative adjuvant oral fluoropyrimidine (UFT or S1) vs. sequential paclitaxel (Factorial Design)for T3/4 gastric carcinoma: the SAMIT Trial | Gastric Cancer | No longer recruiting | Detail | History | ||
| C000000081 2005/09/01 |
Effect of barley Intake on coronary heart disease risk factor, a randomized controlled trial. | Women of aged 50 to 70 years, plasma total cholesterol of 220-280mg/dL, HbA1c of 5.5-6.5%, and without medication for hypertension, hyperlipidemia, and diabetes mellitus. | Completed | Detail | History | ||
| C000000080 2005/09/01 |
Phase I/II study of the combination of docetaxel, CDDP and S-1 in patients with unresectable advanced gastric cancer | unresectable advanced gastric cancer | No longer recruiting | Detail | History | ||
| C000000070 2005/09/01 |
A randomized controlled trial of CT angiography prior to tumor ablation for HCC | Hepatocellular carcinoma | Completed | Detail | History | ||
| C000000024 2005/09/01 |
Smoking cessation program using nicotine replacement therapy for adolescent smokers: A randomized trial | Adolescent smokers aged under 20 years old with nicotine dependence | Detail | History | |||
| C000000099 2005/08/31 |
A Randomized Phase II Clinical Trial of Tailored CPT-11 + S-1 vs S-1 in Patients with Advanced or Recurrent Gastric Carcinoma as the First Line Chemotherapy (JFMC31-0301) | Advanced or recurrent gastric cancer | Completed | Detail | History | ||
| C000000097 2005/08/31 |
A Randomized Phase II study of Carboplatin and Paclitaxel or Gemcitabine and Vinorelbine in ECOG PS2 patients with advanced non-small cell lung cancer | ECOG PS2 patients with advanced non-small cell lung cancer | Completed | Detail | History | ||
| C000000091 2005/08/31 |
PPAR Study | DM patients(HbA1c < 6.5%) with the history of myocardial infarcion | Open public recruiting | Detail | History | ||
| C000000090 2005/08/31 |
ABC Study | Patients With Myocardial Infarction and IGT | Completed | Detail | History | ||
| C000000089 2005/08/31 |
J-WIND-KATP | Patients with AMI who are candidates for PCI(first episode of AMI) | Completed | Detail | History | ||
| C000000088 2005/08/31 |
J-WIND-ANP | Patients with AMI who are candidates for PCI(first episode of AMI) | Completed | Detail | History | ||
| C000000096 2005/08/30 |
Neoadjuvant and adjuvant chemotherapy with ifosfamide and adriamycin for adult high-grade soft tissue sarcomas in the extremities (JCOG0304, Neoadjuvant and adjuvant chemotherapy with IFO/ADM phase II) | soft tissue sarcoma | Main results already published | Detail | History | ||
| C000000095 2005/08/30 |
A phase III study comparing IP with EP following EP/TRT for LD-SCLC JCOG0202-MF | Limited-Stage Small-Cell Lung Cancer | Main results already published | Detail | History | ||
| C000000094 2005/08/30 |
A phase II study of systemic chemotherapy with TS-1 and CDDP followed by surgery in advanced gastric cancer with extensive lymph node metastasis(JCOG0405) | gastric neoplasm | Completed | Detail | History | ||
| C000000093 2005/08/30 |
Comparative study of neoadjuvant MVAC chemotharapy plus radical systectomy with radical cystectomy alone for imparovent of survival of patients with invasive bladder cancer (T2-4aN0M0)(JCOG0209, BC MVAC Phase III) | T2-T4aN0M0 invasive bladder cancer | Completed | Detail | History | ||
| C000000092 2005/08/30 |
Phase II study of ABVd therapy for the previously untreated patients with stage II to IV Hodgkin' s disease (JCOG 9305, LSG14) | previouly untreated advanced stage Hodgkin lymphoma (stage II, III, IVy) | Completed | Detail | History | ||
| C000000087 2005/08/29 |
To evaluate whether two weekly concurrent chemoradiotherapy regimens offer any advantage over concurrent chemoradiotherapy regimens with Cisplatin, Vindesine, Mitomycin for unresectable stage III NSCLC | unresectable stage III NSCLC | Completed | Detail | History | ||
| C000000083 2005/08/29 |
RCT comparing CPFX and CFPM in febrile neutropenic patients with hematologic diseases (C-SHOT 0402 study) | Febrile neutropenia | Completed | Detail | History | ||
| C000000078 2005/08/26 |
Antibiotic Combination Therapy in Patients with Active Refractory Ulcerative Colitis | Ulcerative Colitis | Completed | Detail | History | ||
| C000000075 2005/08/25 |
A Potential Adjuvant Study of Intra-Arterial Hepatic Chemotherapy with 5-FU in Combination with Systemic Chemotherapy (UFT/oral LV) vs Systemic Chemotherapy alone (JFMC32-0501) | Liver excision;liver metastasis cancer of colorectal cancer origin | Completed | Detail | History | ||
| C000000074 2005/08/23 |
VART trial | Hypertension | Preinitiation | Detail | History | ||
| C000000015 2005/08/23 |
Auto blood donation and intraoperative bleeding in hepatic resection | Living liver donor | Detail | History | |||
| C000000073 2005/08/22 |
Phase2 Study of Glivec (imatinib mesylate, formerly known as STI571) in Patients with Relapsed or Refractory Sarcomas with c-kit or PDGFR Expression | Sarcoma with c-kit or PDGFR expression by immunohistochemistry | Terminated | Detail | History | ||
| C000000072 2005/08/22 |
A combination phase I/II study of gemcitabine with carboplatin for previously untreated elderly non-small cell lung cancer | previously untreated elderly non-small cell lung cancer | Completed | Detail | History | ||
| C000000071 2005/08/22 |
Phase II Study of Amrubicin in Patients with Non-Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy | All patients had histologocally or cytologically confirmed locally advanced (non-irradiated) or metastatic NSCLC, with failure of platinum-based chemotherapy (exception for UFT and gefitinib). | Completed | Detail | History | ||
| C000000069 2005/08/19 |
Randomized multicentre trial of antibiotic prophylaxis in elective colorectal surgery: Single dose of cefmetazole vs. three doses of cefmetazole | Colorectal diseases in which elective colorectal resection is necessary | Completed | Detail | History | ||
| C000000068 2005/08/18 |
Phase II study of ABV with increased dose of adriamycin (ADM) and deleted DTIC followed by adjuvant involved-field radiotherapy (ABV/IFRT) to residual or initial bulky tumor for the previously untreated patients with advanced Hodgkin's disease (stage IB, IIB, III, IV or bulky). (JCOG9705) | previouly untreated advanced stage Hodgkin lymphoma (stage IB, IIB, III, IV, or bulky) | Terminated | Detail | History |
